Form 4: Baxter International Executive Reazur Rasul Reports Stock Transactions
SEC Form 4 Filing
EVP Reazur Rasul reports acquisition and disposal of Baxter International stock and stock options on March 6, 2025.
Summary
- On March 6, 2025, Reazur Rasul, an Executive Vice President at Baxter International Inc., reported transactions involving the company's stock.
- Rasul forfeited 9,341 shares to cover tax withholdings related to the settlement of vested restricted stock units at a price of $35.44 per share.
- Rasul also received a grant of 26,220 restricted stock units, which will vest in three equal annual installments starting March 6, 2026.
- Additionally, Rasul was granted options to purchase 87,417 shares of common stock at an exercise price of $35.44, which become exercisable in three equal annual installments beginning March 6, 2026.
- Following these transactions, Rasul directly owns 124,614 shares of Baxter International and holds options for 87,417 shares.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing. The sentiment is neutral as it simply reports transactions.
Positives
- The grant of restricted stock units and stock options to a key executive could be seen as an incentive to drive future performance.
Future Outlook
The restricted stock units and stock options vest over a three-year period, starting March 6, 2026, subject to continued employment and other vesting requirements.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are common in the healthcare industry.
- Companies like Johnson & Johnson, Medtronic, and Abbott also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and terms of these grants are generally in line with industry practices, designed to incentivize long-term performance.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect insider trading activity, which is a normal part of executive compensation.
- Employees may be indirectly affected as executive incentives are designed to improve overall company performance.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of grant for the vested restricted stock units that were settled on March 6, 2025. |
| 03/06/2025 | Date of the reported transactions: stock forfeiture, grant of restricted stock units, and grant of stock options. |
| 03/06/2026 | First vesting date for the restricted stock units and the stock options, with vesting occurring in three equal annual installments. |
| 03/10/2025 | Date of signature on the Form 4 filing. |
| 03/06/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.